Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment

Detalles Bibliográficos
Autores principales: Lin, Swan, Gong, Jason, Canas, George C., Winkle, Peter, Pelletier, Kathleen, LaBadie, Robert R., Ginman, Katherine, Pithavala, Yazdi K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050760/
https://www.ncbi.nlm.nih.gov/pubmed/35258796
http://dx.doi.org/10.1007/s13318-022-00759-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050760/
https://www.ncbi.nlm.nih.gov/pubmed/35258796
http://dx.doi.org/10.1007/s13318-022-00759-8

Ejemplares similares